The effects of pregnancy on autoimmune diseases

Clinical Immunology and Immunopathology

Volumn 78, Issue 2, 1996, Pages 99-104

  Buyon, Jill P ^a   Nelson, J Lee ^b   Lockshin, Michael D ^c  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; PHOSPHOLIPID ANTIBODY;

ADULT; AUTOIMMUNITY; ETIOLOGY; FEMALE; FETUS; HELPER CELL; HLA SYSTEM; HUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

EID: 0029915652     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0018     Document Type: Review

References (57)

1. Wegmann, T. G., Lin, H., Guilbert, L., and Mosmann, T. R., Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol. Today 14, 353-356, 1993.
2. Branch, D. W., Physiologic adaptations of pregnancy. Am. J. Repro. Immunol. 28, 120-122, 1992.
3. Gregory, C. D., Shah, L. P., Lee, H., Scottm, I. V., and Golding, P. R., Cytotoxic reactivity of human natural killer (NK) cells during normal pregnancy. A longitudinal study. J. Clin. Lab. Immunol. 18, 175-181, 1985.
4. Scridama, V., Pacini, F., Yang, S. L., Moawad, A., Reilly, M., and DeGroot, L. J., Decreased levels of helper T cells. A possible cause of immunodeficiency in pregnancy. N. Engl. J. Med. 307, 353-356, 1982.
5. Sites, D. P., and Siiteri, P. K., Steroids as immunosuppressants in pregnancy. Immunol. Rev. 75, 117-138, 1983.
6. Maurolis, G. B., Buckley, R. H., and Younger, J. B., Serum immunoglobulin concentrations during normal pregnancy. Am. J. Obstet. Gynecol. 109, 971-976, 1971.
7. Patton, P. E., Coulam, C. B., and Bergstralth, E., The prevalence of autoantibodies in pregnant and non-pregnant women. Am. J. Obstet. Gynecol. 157, 1345-1350, 1987.
8. Dorner, T., Chaoui, R., Feist, E., Keyber, G., Goldner, B., Yamamoto, K., and Hiepe, F., Significantly increased maternal and fetal autoantibody levels to 52kD Ro (SS-A) and La (SS-B) in complete congenital heart block. J. Autoimmun. in press, 1996.
9. Amino, N., Kuro, R., and Tanizawa, O., et al., Changes of serum anti-thyroid antibodies during and after pregnancy in autoimmune thyroid diseases. Clin. Exp. Immunol. 31, 30-37, 1978.
10. Hunt, J. S., Andrews, G. U., and Wood, G. W., Normal trophoblast resist induction of class I HLA. J. Immunol. 138, 2481-2487, 1987.
11. Payne, R., Leukocyte agglutinins in human sera. Arch. Intern. Med. 99, 587-591, 1957.
12. van der Ven, K., and Ober, C., HLA-G polymorphisms in African-Americans. J. Immunol. 153, 5628-5633, 1994.
13. Hench, P. S., The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrathrosis. Proc. Staff Meet. Mayo Clinic 13, 161-167, 1938.
14. Oka, M., and Vaino, U., Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rheum. Scand. 12, 47-52, 1966.
15. Ostensen, M., Aure, B., and Husby, G., Effects of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand. J. Rheumatol. 12, 69-72, 1983.
16. Pope, R. M., Yoshinoya, S., Rutstein, J., and Persellin, R. H., Effects of pregnancy on the prognosis and serology of rheumatoid arthritis. Am. J. Med. 74, 973-979, 1983.
17. Van den Brink, H. R., van Everdingen, A., van Wijk, M. J. G., Jacobs, J. W. G., and Bjilsma, J. W. J., Adjuvant estrogen therapy has no effect on disease activity in postmenopausal women with active rheumatoid arthritis. Arthritis Rheum. 35, S202, 1992.
18. Wolfson, W. Q., Robinson, W. D., and Duff, I. F., The probability that increased secretion of oxysteroids does not fully explain improvement in certain systemic diseases during pregnancy. J. Michigan State Med. Soc. 50, 1019-1022, 1951.
19. Nelson, J. L., Hughes, K. A., Smith, A. G., Nisperos, B. B., Branchaud, A. M., and Hansen, J. A., Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N. Engl. J. Med. 329, 466-471, 1993.
20. Englehard, V., Structure of peptides associated with class I and class II MHC molecules. Ann. Rev. Immunol. 12, 181-207, 1994.
21. Spector, T., Roman, E., and Silman, A., The pill, parity, and rheumatoid arthritis. Arthritis Rheum. 33, 782-789, 1990.
22. Hazes, J. M. W., Dijkamns, B. A. C., Vandenbroucke, J. P., deVries, R. R. P., and Cats, A., Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum. 33, 1770-1775, 1990.
23. McGill, P. E., and Brougham, P. A., Sex, hormones and rheumatoid arthritis, the nun's story. Br. J. Rheumatol. 29, 159, 1990.
24. Nelson, J. L., Woigt, L. F., Koepsell, T. D., Dugowson, C. E., and Baling, J. R., Pregnancy outcome in women with rheumatoid arthritis before disease onset. Arthritis Rheum. 33, S29, 1990.
25. Lockshin, M. D., Reinitz, E., Druzin, M. L., Murrman, M., and Estes, D., Lupus pregnancy. Case control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am. J. Med. 77, 893-898, 1984.
26. Petri, M., Howard, D., and Repke, J., Frequency of lupus flares in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 34, 1538-1545, 1991.
27. Urowitz, M. B., Gladman, D. D., Farewell, V. T., Stewart, J., and McDonald, J., Lupus and pregnancy studies. Arthritis Rheum. 36, 1392-1397, 1993.
28. Lockshin, M. D., Does lupus flare during pregnancy? Lupus 2, 1-2, 1993. [Editorial]
29. Buyon, J. P., Tamerius, J., Ordorica, S., and Abramson, S. B., Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum. 35, 55-61, 1992.
30. Mintz, J. G., Niz, J., Gutierrez, C., Garcia-Alonso, A., and Karchmer, S., Prospective study of pregnancy in systemic lupus erythematosus: Results of a multidisciplinary approach. J. Rheumatol. 13, 732-739, 1986.
31. Meehan, R. T., and Dorsey, J. K., Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J. Rheumatol. 14, 252-258, 1987.
32. Lockshin, M. D., Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum. 32, 665-670, 1989.
33. Nossent, H. C., and Swaak, T. J., Systemic lupus erythematosus. VI, Analysis of the interrelationship with pregnancy. J. Rheumatol. 17, 771-776, 1990.
34. Tincani, A., Faden, D., Tarantini, M., Lojacono, A., Tanzi, P., and Gastaldi, A., et al., Systemic lupus erythematosus and pregnancy: A prospective study. Clin. Exp. Rheumatol. 10, 439-446, 1992.
35. Buyon, J. P., Seligman, S., Clancy, R., Belmont, H. M., Young, B., and Abramson, S., Increased serum nitrite levels in lupus pregnancies. Arthritis Rheum. 37, S324, 1994. [abstract]
36. Imbasciati, E., Surian, M., Bottino, S., Cosei, P., Colussi, G., Ambroso, C., Massa, E., Minetti, L., and Pardi, G., Lupus nephropathy and pregnancy. Nephron 36, 46-51, 1984.
37. Hayslett, J. P., and Lynn, R. I., Effect of pregnancy in patients with lupus nephropathy. Kidney Int. 18, 207-220, 1980.
38. Lockshin, M. D., Druzin, M. L., and Qamar, T., Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodies. Am. J. Obstet. Gynecol. 160, 439-443, 1989.
39. Lynch, A., Marlar, R., and Murphy, J., et al., Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann. Intern. Med. 120, 470-476, 1994.
40. McNeil, H. P., Simpson, R. J., Chesterman, C. N., and Krilis, S. A., Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87, 4120-4124, 1990.
41. Galli, M., Comfurius, P., and Maassen, C., et al., Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 335, 1544-1547, 1990.
42. Roubey, R. A. S., Pratt, C., Buyon, J. P., and Winfield, J. B., Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I. J. Clin. Invest. 90, 1100-1104, 1992.
43. Lee, N. S., Brewer, H. B., and Osborne, J. C. J., Beta2-glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J. Biol. Chem. 258, 4765-4770, 1983.
44. Schousboe, I., Beta2-glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66, 1086-1091, 1985.
45. Nimpf, J., Bevers, E. M., and Bomans, P. H., et al., Prothrombinase activity of human platelet is inhibited by beta 2 glycoprotein I. Biochem. Biophys. Acta 884, 142-149, 1986.
46. Nimpf, J., Wurm, H., and Kostner, G. M., Beta 2-glycoprotein I (apo-H) inhibits the release reaction of human platelet during ADP-induced aggregation. Atherosclerosis 63, 109-114, 1987.
47. Branch, D. W., Thoughts on the mechanism of pregnancy loss associated with the anti-phospholipid syndrome. Lupus 3, 275-280, 1994.
48. Cowchock, F. S., Reece, E. A., Balaban, D., Branch, D. W., and Plouffle, L., Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am. J. Obstet. Gynecol. 166, 1318-1323, 1992.
49. Branch, D. W., Silver, R. M., Blackwell, J. L., Reading, J. C., and Scott, J. R., Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol. 80, 614-620, 1992.
50. Buyon, J. P., Neonatal lupus syndromes. In "Systemic Lupus Erythematosus" (R. Lahita, Ed.), Churchill Livingstone, 1992.
51. Lee, L. A., Neonatal lupus erythematosus. J. Invest. Dermatol. 100, 9S-13S, 1993.
52. Buyon, J. P., Winchester, R. J., Slade, S. G., Arnett, F., Copel, J., Friedman, D., and Lockshin, M. D., Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children: Comparison of ELISA and immunoblot to measure anti-SSA/Ro and anti-SSB/La antibodies. Arthritis Rheum. 36, 1263-1273, 1993.
53. Waltuck, J., and Buyon, J. P., Autoantibody associated complete heart block: Outcome in mothers and children. Ann. Intern. Med. 120, 544-551, 1994.
54. Garcia, S., Nascimento, J. H. M., Bonfa, E., Levy, R., Oliveira, S. F., Tavares, A. V., and Campos deCarvalho, A. C., Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J. Clin. Invest. 93, 718-724, 1994.
55. ca). Arthritis Rheum., 38, S230, 1995. [Abstract]
56. Rider, L., Buyon, J., Rutledge, J., and Sherry, D., Postnatal treatment of neonatal lupus: Case report and review of the literature. J. Rheum. 20, 1208-1211, 1993.
57. Copel, J., Buyon, J., and Kleinman, C., Successful in utero therapy of fetal heart block. Am. J. Obstet. Gynecol., in press, 1995.